Tag: Vaccines
Physician’s Briefing Weekly Coronavirus Roundup
FDA Postpones Decision on Pfizer COVID-19 Vaccine for Under 5s
Step was taken after Pfizer notified the agency it would like to wait until data are available on a three-dose regimen
Adverse Events After BNT162b2 Do Not Differ for Cancer Patients
Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment
Homologous, Heterologous COVID-19 Boosters Are Immunogenic
Antibody neutralizing titers against SARS-CoV-2 D614G pseudovirus increased by factor of 4 to 73 for all combinations
CDC Backs Full Approval of Moderna COVID-19 Vaccine
Moderna vaccine is the second COVID-19 vaccine to receive full approval from both the FDA and CDC
Physician’s Briefing Weekly Coronavirus Roundup
COVID-19 mRNA Vaccination Does Not Impair IVF Outcomes
No association seen between vaccine administration and fertilization rates or early pregnancy outcomes
Intention to Receive COVID-19 Vaccine Has Grown Faster Among Black Adults
Persistent lower vaccination rate in Black adults might be explained by other factors besides hesitancy
Pfizer Asks FDA to Approve Its Vaccine for the Youngest Children
An FDA advisory panel will weigh the two-dose regimen on Feb. 15
Risk for Breakthrough SARS-CoV-2 Infection Lower With mRNA-1273
Risk for breakthrough infection and of 60-day hospitalization significantly lower for mRNA-1273 versus BNT162b2 vaccination
